Scroll to the bottom of the page to pay your bill

Increasing Survival Rates For ‘incurable’ Cancer

High-dose Radiation May be the Answer

Research presented at the 2018 Annual Meeting of the American Society for Radiation Oncology (ASTRO) suggests that high-dose radiation therapy improves survival for oligometastatic patients. When patients have cancer that spreads to the rest of their body like their bones or brain, in the past they would have been considered incurable.

“There’s a theory—called the oligometastatic theory—that if a patient only has a few spots of cancer returning, those spots could be killed with radiation or surgery to improve their survival.” In a prepared statement, lead author of the research, David Palma (MD, Ph.D.) stated, “Now, we’ve been able to show, for the first time in a randomized trial, that high-dose radiation can effectively treat these limited recurrences, and we’ve been able to increase survival by a median of 13 months.”

Palma et al. enrolled 99 patients from Scotland, the Netherlands, Australia, and Canada in what researchers have called the first randomized clinical trial of its kind. Participants all had recurring cancer after receiving previous treatment. All had life expectancies over six months.

The trial spanned four years, from 2012 to 2016. Participants were assigned randomly into two treatment groups: palliative standard of care (SOC) treatments and SOC treatments plus stereotactic body radiation therapy (SBRT)—in a 1:2 ratio.

According to Palma’s statement, the group with SBRT treatments lived “considerably longer” than the group who received SOC treatments alone. The median survival was 41 months overall for the SBRT group while the SOC-only group’s overall survival was 28 months. Additionally, the participants in the SBRT group doubled how they lived without any cancer growth.

SBRT is associated with “severe side effects,” including death. Palma, however, explains, “for patients whose cancers have spread, and who are not expected to survive otherwise,” the benefit outweighs the risks. 

You Might Also Enjoy...

Are You at Risk for Ovarian Cancer?

It would be great if we had a crystal ball to tell us which illnesses we’ll get and how to avoid them. Until we do, the next best thing is to know your risk factors for certain diseases, including ovarian cancer.

How MammoSite® Therapy Works

After your breast cancer diagnosis, your mind turns immediately to treatments. You want the most effective, least invasive option possible. Here’s why MammoSite® targeted radiation therapy may be the best answer.

How Long Does Hair Loss Last With Chemo or Radiation?

You’d give up almost anything for a chance to beat your cancer. And many treatments will test your resolve to do just that. Hair loss is one of the sacrifices most-often associated with chemo and radiation. Here’s what you can expect.

How Hormone Therapy Works to Combat Cancer

Most people are familiar with radiation and chemotherapy as effective go-to treatments, but there are many more cancer-fighting weapons in our arsenal. Here’s how hormone therapy may be a key player in your cancer treatment plan.